Glucagon (1-29), bovine, human
Based on 14 publication(s) in Google Scholar
Glucagon (1-29), bovine, human, porcine is a peptide hormone, produced by pancreatic α-cells. Glucagon stimulates gluconeogenesis. Glucagon (1-29), bovine, human, porcine activates HNF4α and increases HNF4α phosphorylation.
For research use only. We do not sell to patients.
- Purity: 99.91%
- CAS No.: 16941-32-5
- Formula: C153H225N43O49S
- Molecular Weight:3482.75
-
Storage:
Sealed storage, away from moisture and light.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Glucagon (1-29), bovine, human
More- Cell Res. 2023 Apr;33(4):273-287. [Abstract]
- Nat Metab. 2025 Feb;7(2):367-382. [Abstract]
- Nat Metab. 2022 Jan;4(1):29-43. [Abstract]
- Exp Mol Med. 2026 May;58(5):1536-1555. [Abstract]
- Metabolism. 2025 Jan:162:156049. [Abstract]
- Mol Cell. 2023 Apr 6;83(7):1093-1108.e8. [Abstract]
- Phytomedicine. 2021 Mar:83:153487. [Abstract]
- Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3144-3149. [Abstract]
- Food Sci Hum Wellness. 2026 Apr 3.
- J Med Chem. 2026 Feb 26;69(4):4984-5001. [Abstract]
- Cell Mol Life Sci. 2026 Jul 1. [Abstract]
- Endocrinology. 2023 Jan 9;164(3):bqac217. [Abstract]
- Patent. US20230021840A1.
- Research Square Preprint. 2021 May.
Customer Validation & Images
-
Bio/Physico-chemical Assay
-
RT-PCR
-
Cell Imaging/Staining
-
Cell Imaging/Staining
-
Bio/Physico-chemical Assay
Biological Activity
Upon binding to its receptor Gcgr, Glucagon activates cAMP-PKA signaling to stimulate hepatic glucose production (HGP) and cause hyperglycemia[1].
Glucagon stimulates both hepatic kisspeptin1 production and gluconeogenesis[1].
Glucagon (100 nM) represses CYP7A1 mRNA expression in human primary hepatocytes[3].
Glucagon (100 nM) increases phosphorylayion of HNF4α[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human primary hepatocytes (H1211, HH1215)
-
Concentration:100 nM
-
Incubation Time:
-
Result:Resulted in a marked increase in the amount of phosphorylated HNF4α.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J mice (12- to 24-week-old)[4]
-
Dosage:20 μg/kg and 1 mg/kg
-
Administration:Administered by i.p. injection; 45 minutes
-
Result:Low-dose (20 μg/kg) increased glycemia and did not stimulate insulin secretion.
High-dose (1 mg/kg) lowered glycemia and stimulated insulin secretion.
Chemical Information
-
CAS No. 16941-32-5
-
Appearance Solid
-
Molecular Weight 3482.75
-
Formula C153H225N43O49S
-
Color White to off-white
-
Synonyms
Glucagon
-
Sequence
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr
-
Sequence Shortening
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture and light
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (14)
-
Journal Impact Factor
-
Most Recent
-
Cell Res
Famsin, a novel gut-secreted hormone, contributes to metabolic adaptations to fasting via binding to its receptor OLFR796. [Abstract]2023 Apr;33(4):273-287. PMID: 36806353
Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Cell Res. 2023 Apr;33(4):273-287. [Abstract]
Effect of 10 min treatment with famsin (30 nM) or Glucagon (100 nM) on cellular cAMP levels in mouse primary hepatocytes.
-
Nat Metab
2025 Feb;7(2):367-382. PMID: 39820557
Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382. [Abstract]
Glucose production in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h compared to control cells, n = 4.
Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382. [Abstract]
Neat1 level in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h, n = 4.
Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382. [Abstract]
Representative images showing cellular distribution of Neat1_2 (green) and NONO (red) in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h. The graph plots the fluorescence intensity of each probe or protein (y-axis) vs. distance (x-axis) for the corresponding white line.
Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382. [Abstract]
Quantification of paraspeckle numbers in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h, n = 40 cells per group.
-
Nat Metab
2022 Jan;4(1):29-43. PMID: 34992299 -
Exp Mol Med
Hepatocyte estrogen-related receptor α modulates a gluconeogenic-epigenetic crosstalk counteracting MASLD/MASH progression. [Abstract]2026 May;58(5):1536-1555. PMID: 42104013 -
Metabolism
ZBED3 exacerbates hyperglycemia by promoting hepatic gluconeogenesis through CREB signaling. [Abstract]2025 Jan:162:156049. PMID: 39454821 -
Mol Cell
Histone phosphorylation integrates the hepatic glucagon-PKA-CREB gluconeogenesis program in response to fasting. [Abstract]2023 Apr 6;83(7):1093-1108.e8. PMID: 36863348 -
Phytomedicine
A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway. [Abstract]2021 Mar:83:153487. PMID: 33636476 -
Proc Natl Acad Sci U S A
2020 Feb 11;117(6):3144-3149. PMID: 32001509 -
-
J Med Chem
Discovery and Preclinical Evaluation of TPM003: A Novel GLP-1/GIP/Glucagon Triple Hormone Receptor Agonist with Robust Efficacy in Obesity and NASH. [Abstract]2026 Feb 26;69(4):4984-5001. PMID: 41640214 -
Cell Mol Life Sci
Ablation of the renal tubular gluconeogenic enzyme PCK1 drives AKI-to-CKD transition by negatively regulating the TGF-β/Smad3 signaling pathway. [Abstract]2026 Jul 1. PMID: 42380498 -
Endocrinology
Aspirin Suppresses Hepatic Glucagon Signaling Through Decreasing Production of Thromboxane A2. [Abstract]2023 Jan 9;164(3):bqac217. PMID: 36592127 -
-
Solvent & Solubility
H2O : 6.67 mg/mL (1.92 mM; ultrasonic and adjust pH to 3 with HCl)
DMSO : 2 mg/mL (0.57 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 0.2 mg/mL (0.06 mM); Clear solution
This protocol yields a clear solution of ≥ 0.2 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (2.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 0.2 mg/mL (0.06 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 0.2 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (2.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (286 KB)
-
SDS (558 KB)
- English - EN (558 KB)
- Français - FR (558 KB)
- Deutsch - DE (558 KB)
- Norwegian - NO (558 KB)
- Español - ES (558 KB)
- Swedish - SV (558 KB)
- Italian - IT (558 KB)
- Korean - KR (558 KB)
- Portuguese - PT (558 KB)
-
Handling Instructions (2659 KB)
References
[1]. Song WJ, et al. Glucagon regulates hepatic kisspeptin to impair insulin secretion. Cell Metab. 2014 Apr 1;19(4):667-81. [Content Brief]
[2]. Hirota K, et al. Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. J Biol Chem. 2003 Apr 11;278(15):13056-60. [Content Brief]
[3]. Song KH, et al. Glucagon and cAMP inhibit cholesterol 7alpha-hydroxylase (CYP7A1) gene expression in humanhepatocytes: discordant regulation of bile acid synthesis and gluconeogenesis. Hepatology. 2006 Jan;43(1):117-25. [Content Brief]
[4]. Capozzi ME, et al. Glucagon lowers glycemia when β-cells are active. JCI Insight. 2019 Jul 23;5. pii: 129954. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 0.2871 mL | 1.4356 mL | 2.8713 mL | 7.1782 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Glucagon (1-29), bovine, human Related Classifications
HY-P0082 Related Classifications
Powered by Bioz